Beginning as a small local pharmacy in Jerusalem in the early 1980s, Rekah soon grew into a pharmaceutical trade store in the Jerusalem area. The pharmaceutical trade store continued to grow during the 1980s, adding suppliers and extending its distribution nationwide.
During the 1990s, the company expanded its activities to include production, acquiring its first production plant in Holon, Israel (Rekah). In 1994, the company went public on the Tel Aviv Stock Exchange (REKA).
The company continued to expand its production capabilities and acquired a big production site in Binyamina, Israel (Vitamed) in 2003. In 2008, the company entered the field of natural products and vitamins as part of the Derech Haim brand.
From 2012 to 2018, production infrastructures were expanded, an R&D unit was established and the company promoted registration and export of its products abroad. In 2015, FIMI, the leading private equity fund in Israel, became a partner in the company.
In 2019, the investment plan was accelerated in order to support the TEVA deal and the company's production of the relevant TEVA products, as well as preparations for exporting core products to Europe. In addition, the company built a modern logistics center in central Israel.In 2021, Rekah acquired “Tree of Life”, a company that develops, manufactures, imports, markets and sells innovative medical devices and health products. This is the first strategic and synergistic acquisition of the Rekah Group, which allows it to enter the growing medical device field in Israel and around the world. This acquisition opens the door to a significant growth channel in Israel and abroad by immediately expanding the product portfolio with innovative products in new areas, marketing registration and distribution infrastructure in foreign markets, regulatory capabilities, and development in the field of medical devices. The acquisition of “Tree of Life” strengthens the position of the Rekah Group as a leading pharmaceutical company in Israel.